Sleep Apnea and Heart Failure

Heart failure is a chronic condition in which the heart cannot pump enough blood to meet the body's needs. It does not mean the heart has stopped — rather, it means the heart muscle is weakened or stiff, reducing its ability to circulate blood effectively. The term congestive heart failure refers to the fluid buildup that often accompanies this condition, particularly in the lungs, legs, and feet.

Common causes of heart failure include coronary artery disease, previous heart attacks, longstanding high blood pressure, and valve disease. Symptoms include shortness of breath, fatigue, swelling in the legs and ankles, rapid or irregular heartbeat, and difficulty exercising.

Heart failure is a serious, progressive condition that requires ongoing medical management. What many patients and even some providers may not realize is how frequently sleep apnea coexists with heart failure — and how significantly untreated sleep apnea can worsen heart failure outcomes.

Obstructive sleep apnea (OSA) is the more familiar type of sleep apnea, occurring when the muscles around the airway relax during sleep, allowing the airway to collapse and block breathing. It is the most common form of sleep apnea in the general population and is also common in heart failure patients.

In a heart failure patient, the effects of OSA are amplified. Each apnea event causes oxygen levels to drop and triggers the fight-or-flight stress response, spiking blood pressure and heart rate. The negative pressure created in the chest as the person struggles to breathe against the blocked airway increases the workload on the heart — particularly the right side, which must pump against elevated pulmonary pressure.

Over time, this repeated stress can worsen heart failure. Studies show that heart failure patients with untreated OSA have higher rates of hospitalization and worse outcomes compared to those whose sleep apnea is treated. Treatment with CPAP or oral appliance therapy can reduce this cardiovascular stress.

Central sleep apnea (CSA) is less common in the general population but is particularly prevalent among heart failure patients. Unlike OSA, there is no physical airway blockage. Instead, the brain temporarily fails to send the signals that tell the body to breathe. The person simply stops breathing for a period, then resumes.

CSA in heart failure is often related to a condition called Cheyne-Stokes respiration — a pattern of alternating periods of deep, rapid breathing and pauses. This occurs because the heart's reduced pumping ability causes changes in blood flow and carbon dioxide levels that disrupt the brain's breathing control center.

This distinction is critical because the treatment for CSA differs from OSA. While OSA is typically treated with CPAP or oral appliances, CSA may require different therapies such as adaptive servo-ventilation (ASV), which provides customized breathing support. This is why proper diagnosis through a comprehensive sleep study is so important.

In heart failure, the heart is already struggling to deliver adequate oxygen to the body. When sleep apnea causes repeated drops in blood oxygen — a condition called intermittent hypoxia — the burden on the heart increases dramatically.

Each oxygen drop forces the heart to pump harder and faster to compensate. The stress hormone surges that accompany each apnea event further increase the workload. The pressure changes in the chest during obstructive events add yet another layer of strain.

Over time, this nightly stress can:

• Worsen the heart's pumping ability, reducing ejection fraction
• Promote enlargement and thickening of the heart muscle
• Increase the risk of dangerous arrhythmias
• Contribute to fluid retention, worsening congestion
• Increase the frequency of heart failure hospitalizations

Learn more about the oxygen dynamics in our sleep apnea and low oxygen guide.

Because heart failure patients can have either obstructive or central sleep apnea — or sometimes both — proper diagnosis is essential. A comprehensive in-lab sleep study (polysomnography) is typically recommended for heart failure patients, as it can distinguish between OSA and CSA and detect Cheyne-Stokes respiration.

Home sleep tests, while convenient, may not provide enough detail to differentiate between obstructive and central events in heart failure patients. An in-lab study monitors brain waves, breathing effort, oxygen levels, heart activity, and other signals simultaneously, allowing the physician to make an accurate diagnosis.

The treatment implications are significant:

• OSA in heart failure is typically treated with CPAP or oral appliance therapy
• CSA may require adaptive servo-ventilation (ASV) or other specialized therapies
• Treating the wrong type can be ineffective or potentially harmful
• Some patients have both types, requiring a combined treatment approach

If you have heart failure and haven't been evaluated for sleep apnea, consider discussing a sleep study with your cardiologist. Learn more about sleep testing options or take our sleep apnea assessment.